| Divis Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532488 |
NSE Symbol : DIVISLAB |
P/E(TTM) : 68.36 |
|
ISIN Demat : INE361B01024 |
Div & Yield% : 0.46 |
EPS(TTM) : 94.70 |
|
Book Value(₹) : 578.26 |
Market Cap(₹Cr) : 171,847.10 |
Face Value(₹) : 2.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 2,660.00 | 2,357.00 | 2,536.00 | 2,297.00 | 2,302.00 | 2,063.00 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2,660.00 | 2,357.00 | 2,536.00 | 2,297.00 | 2,302.00 | 2,063.00 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 146.00 | 119.00 | 87.00 | 82.00 | 105.00 | 79.00 |
| Total Income | 2,806.00 | 2,476.00 | 2,623.00 | 2,379.00 | 2,407.00 | 2,142.00 |
| Total Expenditure | 1,765.00 | 1,614.00 | 1,655.00 | 1,550.00 | 1,573.00 | 1,442.00 |
| PBIDT | 1,041.00 | 862.00 | 968.00 | 829.00 | 834.00 | 700.00 |
| Interest | 8.00 | 3.00 | 0.00 | 0.00 | 1.00 | 0.00 |
| PBDT | 1,033.00 | 859.00 | 968.00 | 829.00 | 833.00 | 700.00 |
| Depreciation | 113.00 | 112.00 | 107.00 | 99.00 | 98.00 | 97.00 |
| Tax | 220.00 | 191.00 | 225.00 | 172.00 | 218.00 | 178.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 4.00 | -1.00 | -31.00 | -36.00 | -1.00 | -5.00 |
| Reported Profit After Tax | 696.00 | 557.00 | 667.00 | 594.00 | 518.00 | 430.00 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 696.00 | 557.00 | 667.00 | 594.00 | 518.00 | 430.00 |
| EPS (Unit Curr.) | 26.24 | 20.95 | 25.12 | 22.39 | 19.51 | 16.18 |
| EPS (Adj) (Unit Curr.) | 26.24 | 20.95 | 25.12 | 22.39 | 19.51 | 16.18 |
| Calculated EPS (Unit Curr.) | 26.26 | 21.02 | 25.17 | 22.42 | 19.55 | 16.23 |
| Calculated EPS (Adj) (Unit Curr.) | 26.26 | 21.02 | 25.17 | 22.42 | 19.55 | 16.23 |
| Calculated EPS (Ann.) (Unit Curr.) | 105.06 | 84.08 | 100.68 | 89.66 | 78.19 | 64.91 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 105.06 | 84.08 | 100.68 | 89.66 | 78.19 | 64.91 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 53.00 | 53.00 | 53.00 | 53.00 | 53.00 | 53.00 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 39.14 | 36.57 | 38.17 | 36.09 | 36.23 | 33.93 |
| PBDTM(%) | 38.83 | 36.44 | 38.17 | 36.09 | 36.19 | 33.93 |
| PATM(%) | 26.17 | 23.63 | 26.30 | 25.86 | 22.50 | 20.84 |